On the Estimation of Survival Time and Identification

Gurprit Grover

ISBN 10: 333006577X / ISBN 13: 9783330065772

Published by LAP LAMBERT Academic Publishing Apr 2019, 2019

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -Developing countries are undergoing a rapid epidemiological transition - from infectious diseases such as diarrhoea and pneumonia to chronic ones such as heart disease, liver disease, diabetes, cancer, arthritis etc - that threatens to overwhelm their strapped health systems and cripple their fragile economies (Heidi Worley, 2006). Chronic conditions and diseases are leading cause of mortality and morbidity, accounting for 60% of total premature deaths all over world out of which 53% is in India (WHO). Liver disease represents a major problem for the health care systems and of course, for the patients. Especially chronic liver disease is a growing problem. One third of the world's total population (2 billion) has been infected with hepatitis B virus of whom more than 350 million people (perhaps 400 million) are inflicted by chronic HBV and about 170 million by hepatitis C. 20% of those patients with chronic liver diseases from viral hepatitis might develop a liver cirrhosis which might end in the need of a liver transplantation. 156 pp. Englisch.

Seller Inventory # 9783330065772

Bibliographic Details

• Title: On the Estimation of Survival Time and Identification
• Publisher: LAP LAMBERT Academic Publishing Apr 2019
• Publication Date: 2019
• Language: English
• ISBN 10: 333006577X
• ISBN 13: 9783330065772
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 10D millimeters 220 millimeters width by 150 millimeters height by 10 millimeters depth
• Weight: 250 grams

About this title

Synopsis

Developing countries are undergoing a rapid epidemiological transition - from infectious diseases such as diarrhoea and pneumonia to chronic ones such as heart disease, liver disease, diabetes, cancer, arthritis etc - that threatens to overwhelm their strapped health systems and cripple their fragile economies (Heidi Worley, 2006). Chronic conditions and diseases are leading cause of mortality and morbidity, accounting for 60% of total premature deaths all over world out of which 53% is in India (WHO). Liver disease represents a major problem for the health care systems and of course, for the patients. Especially chronic liver disease is a growing problem. One third of the world's total population (2 billion) has been infected with hepatitis B virus of whom more than 350 million people (perhaps 400 million) are inflicted by chronic HBV and about 170 million by hepatitis C. 20% of those patients with chronic liver diseases from viral hepatitis might develop a liver cirrhosis which might end in the need of a liver transplantation.